Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Nashat Amir
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-05-21
Sale
2021-05-25
7:20 pm
Morphic Holding Inc. MORF Nashat Amir
Director
232,295 $45.5 $10,569,423 136,691
(Indirect)
View
2020-09-18
Purchase
2020-09-22
5:10 pm
Metacrine Inc. MTCR Nashat Amir
Director
10% Owner
230,000 $13 $2,990,000 178,942
(Indirect)
View
2019-07-31
Sale
2019-08-02
4:32 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
62,005 $22.53 $1,397,066 11,034
(Indirect)
View
2019-07-26
Sale
2019-07-30
6:25 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
118,333 $22.51 $2,663,115 11,635
(Indirect)
View
2019-07-23
Sale
2019-07-25
6:24 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
81,899 $22.51 $1,843,151 12,781
(Indirect)
View
2019-07-18
Sale
2019-07-22
5:52 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
71,166 $22.52 $1,602,506 13,574
(Indirect)
View
2019-07-01
Purchase
2019-07-01
7:19 pm
Morphic Holding Inc. MORF Nashat Amir
Director
125,000 $15 $1,875,000 151,879
(Indirect)
View
2019-01-30
Sale
2019-02-01
5:02 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
53,017 $14.16 $750,959 1,473,186
(Indirect)
View
2019-01-29
Sale
2019-01-31
6:00 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
97,500 $14.16 $1,380,795 1,526,203
(Indirect)
View
2019-01-28
Sale
2019-01-30
4:10 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
70,000 $13.78 $964,768 1,623,703
(Indirect)
View
2019-01-25
Purchase
2019-01-29
4:37 pm
SELECTA BIOSCIENCES INC SELB Nashat Amir
Director
1,166,666 $1.5 $1,749,999 2,676,234
(Indirect)
View
2019-01-25
Sale
2019-01-29
4:31 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
90,000 $14.14 $1,272,753 1,693,703
(Indirect)
View
2019-01-18
Sale
2019-01-23
4:32 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
39,483 $16.28 $642,834 1,783,703
(Indirect)
View
2018-12-20
Sale
2018-12-26
4:13 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
33,474 $12.25 $410,160 1,823,186
(Indirect)
View
2018-12-19
Sale
2018-12-21
4:12 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
91,210 $13.4 $1,222,592 1,856,660
(Indirect)
View
2018-12-13
Sale
2018-12-17
4:25 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
17,788 $16.67 $296,563 1,947,870
(Indirect)
View
2018-12-12
Sale
2018-12-14
4:33 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
425,000 $16.78 $7,132,690 1,965,658
(Indirect)
View
2018-12-11
Sale
2018-12-13
5:14 pm
FATE THERAPEUTICS INC FATE Nashat Amir
Director
82,528 $16.71 $1,379,183 2,390,658
(Indirect)
View
2018-05-29
Purchase
2018-05-31
9:42 pm
Scholar Rock Holding Corp SRRK Nashat Amir
Director
10% Owner
142,857 $14 $1,999,998 156,395
(Indirect)
View
2017-09-26
Sale
2017-09-28
5:10 pm
SELECTA BIOSCIENCES INC SELB Nashat Amir
Director
70,226 $18.91 $1,328,079 1,550,478
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-11-17
Other
2021-11-19
4:32 pm
N/A
N/A
Scholar Rock Holding Corp SRRK Nashat Amir
Director
346,721 $0 409,989
(Indirect)
View
2021-06-16
Option Award
2021-06-17
7:12 pm
N/A
2031-06-16
Morphic Holding Inc. MORF Nashat Amir
Director
12,000 $0 12,000
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:29 pm
N/A
2031-06-07
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
17,500 $0 17,500
(Direct)
View
2021-05-27
Option Award
2021-06-01
4:11 pm
N/A
2031-05-27
Scholar Rock Holding Corp SRRK Nashat Amir
Director
7,800 $0 7,800
(Direct)
View
2021-05-24
Option Award
2021-05-25
7:03 pm
N/A
2031-05-23
Metacrine Inc. MTCR Nashat Amir
Director
10% Owner
16,500 $0 16,500
(Direct)
View
2020-09-18
Conversion
2020-09-22
5:10 pm
N/A
N/A
Metacrine Inc. MTCR Nashat Amir
Director
10% Owner
2,664,258 $0 178,942
(Indirect)
View
2020-09-15
Ownership
2020-09-15
5:11 pm
N/A
N/A
Metacrine Inc. MTCR Nashat Amir
Director
10% Owner
0 $0 2,664,258
(Indirect)
View
2020-06-18
Option Award
2020-06-19
6:20 pm
N/A
2030-06-18
Morphic Holding Inc. MORF Nashat Amir
Director
12,000 $0 12,000
(Direct)
View
2020-06-16
Option Award
2020-06-18
4:24 pm
N/A
2030-06-16
Scholar Rock Holding Corp SRRK Nashat Amir
Director
10% Owner
13,000 $0 13,000
(Direct)
View
2020-06-11
Option Award
2020-06-11
4:52 pm
N/A
2030-06-10
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
17,500 $0 17,500
(Direct)
View
2019-07-01
Conversion
2019-07-01
7:19 pm
N/A
N/A
Morphic Holding Inc. MORF Nashat Amir
Director
2,197,946 $0 151,879
(Indirect)
View
2019-06-26
Ownership
2019-06-26
9:25 pm
N/A
N/A
Morphic Holding Inc. MORF Nashat Amir
Director
0 $0 2,221,946
(Direct)
View
2019-06-14
Option Award
2019-06-18
4:21 pm
N/A
2029-06-13
SELECTA BIOSCIENCES INC SELB Nashat Amir
Director
10,000 $0 10,000
(Direct)
View
2019-06-11
Option Award
2019-06-12
4:15 pm
N/A
2029-06-10
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
11,000 $0 11,000
(Direct)
View
2019-05-21
Option Award
2019-05-23
9:41 pm
N/A
2029-05-21
Scholar Rock Holding Corp SRRK Nashat Amir
Director
10% Owner
10,158 $0 10,158
(Direct)
View
2019-05-03
Option Award
2019-05-07
4:06 pm
N/A
2029-05-03
FATE THERAPEUTICS INC FATE Nashat Amir
Director
16,000 $0 16,000
(Direct)
View
2018-06-22
Option Award
2018-06-26
5:32 pm
N/A
2028-06-22
Scholar Rock Holding Corp SRRK Nashat Amir
Director
10% Owner
20,316 $0 20,316
(Direct)
View
2018-06-15
Option Award
2018-06-19
7:03 pm
N/A
2028-06-14
SELECTA BIOSCIENCES INC SELB Nashat Amir
Director
10,000 $0 10,000
(Direct)
View
2018-06-14
Option Award
2018-06-15
4:29 pm
N/A
2028-06-13
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
11,000 $0 11,000
(Direct)
View
2018-05-29
Conversion
2018-05-31
9:42 pm
N/A
N/A
Scholar Rock Holding Corp SRRK Nashat Amir
Director
10% Owner
10,368,831 $0 156,395
(Indirect)
View
2018-05-23
Ownership
2018-05-23
9:46 pm
N/A
N/A
Scholar Rock Holding Corp SRRK Nashat Amir
Director
10% Owner
0 $0 2,689,849
(Indirect)
View
2018-05-15
Option Award
2018-05-17
4:36 pm
N/A
2028-05-15
aTYR PHARMA INC LIFE Nashat Amir
Director
20,000 $0 20,000
(Direct)
View
2018-05-02
Option Award
2018-05-04
4:19 pm
N/A
2028-05-02
FATE THERAPEUTICS INC FATE Nashat Amir
Director
16,000 $0 16,000
(Direct)
View
Goto 0, 1, Next